Inspiralis
Inspiralis provides high quality topoisomerase products to both the pharmaceutical industry and academia supported by our highly trained and experienced scientific staff. Specialising in supplying topoisomerases (including bacterial gyrases, topo IV, human topoisomerases I and II and the substrates supercoiled and relaxed pBR322 and kDNA) and providing topoisomerase inhibitor screening assays (both low- and high-throughput), we aim to enhance research into the hugely important anti-infectives and anti-cancer markets.
We also provide contract cloning, expression and purification of topoisomerases.
New Products
We are now able to offer the following enzymes, both alone and as kits.
Staphylococcus aureus gyrase, Staphylococcus aureus topo IV, Mycobacterium tuberculosis gyrase and wheat germ topo I
Pseudomonas aeruginosa and Streptococcus pneumoniae gyrase and topo IV will also be available in the autumn
These enzymes are also available in a medium- to high-throughput assay system
News
We will be attending ICAAC 2010 in Boston in September.
Please contact us at contact@inspiralis.co.uk if you would like to meet up with us at ICAAC to discuss your topoisomerase based research. Our scientists are also happy to visit researchers / companies in the area at this time, so if you have a topoisomerase related problem we can offer advice and help in your own labs. Just contact us at the link above for further details.
Inspiralis Limited, Registered Office: Norwich BioIncubator, Norwich Research Park, Colney, Norwich, Norfolk, NR4 7UH, UK. Inspiralis Limited is a company registered in England and Wales with company number 5837417. VAT number 904395032